New boss at MSD Ballydine heads up a team of over 450

04/11/2014Ger Carmody, Head of MSD Site, Ballydine, Co. Tipperary.Picture: Don Moloney / Press 22
Leading healthcare company, MSD, has appointed Ger Carmody as Associate Vice President, Plant Management, for its site in Ballydine, Co. Tipperary.

Leading healthcare company, MSD, has appointed Ger Carmody as Associate Vice President, Plant Management, for its site in Ballydine, Co. Tipperary.

In this role, Ger will be responsible for overall operations and management of the Ballydine facility, leading a team of over 450 highly-skilled people with a core focus on a range of new and innovative products that are developed and supplied by MSD for export across the globe.

Ger was previously the Executive Director of MSD in Hangzhou, China, where he spent three years as plant manager for the existing manufacturing facility and project lead for the construction and start-up of a new manufacturing site to supply Asia Pacific markets. Prior to that, he held the role of Director of Technical Operations for the Asia Pacific region at MSD in Singapore.

Ger holds a Degree in Chemical Engineering from UCD and is a chartered member of the Institute of Chemical Engineers.

MSD in Ballydine develops innovative methods for the formulation and supply of new products and houses a Formulation R&D and Manufacturing Facility on-site.

The plant exports to over 30 countries with main markets being Europe, USA and Japan.

MSD, known as Merck in the US and Canada, has operations in more than 140 countries. In Ireland, the company employs over 2,000 people across its five sites in Dublin, Carlow, Cork, Tipperary and Wicklow where its extensive operations encompass manufacturing, commercial and marketing facilities.

MSD is a leader in healthcare, dedicated to helping the world be well through a wide range of innovative health solutions. This includes the development, production and distribution of prescription medicines, vaccines and biologic therapies as well as animal health products.

MSD’s commitment to research and to increasing access to healthcare across the world is demonstrated by clearly focused policies, far-reaching programmes and life-enhancing partnerships.